Iain manages the Bioanalysis and Biotransformation team at XenoGesis and is responsible for maintaining the instruments and developing methods for the more problematic compounds.

With a background in biotransformation and LC/MS, Iain’s primary scientific role is responsibility for the metabolite identification studies conducted within the company. He also works on evaluating new technology, instruments and techniques that may lead to new capabilities for the company.

Iain joined XenoGesis in 2013 from AstraZeneca and has over 30 years of experience working within DMPK. He is an experienced mass spectroscopist and has worked in DMPK throughout his career as a biotransformation scientist providing metabolite identification support to both discovery and development projects.

Iain Beattie PhD

Director of Bioanalysis and Biotransformation

Talk to a scientist... if you’d like to get in touch with one our scientists, please click here!